Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis)
1 clinical trials · Condition
◉ Watch Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis)
| Record | Firm | Date |
|---|---|---|
| FASENRA Regulatory Postmarketing Surveillance in Korea (NCT05091333) | AstraZeneca | 2022-03-11 |
Track Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis) automatically
Every clearance here is in the API, with alerts when new ones post.